Literature DB >> 61473

Chromosome aberrations and metronidazole.

F Mitelman, B Hartley-Asp, B Ursing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 61473     DOI： 10.1016/s0140-6736(76)90636-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Double blind, placebo controlled trial of metronidazole in Crohn's disease.

Authors:  L Sutherland; J Singleton; J Sessions; S Hanauer; E Krawitt; G Rankin; R Summers; H Mekhjian; N Greenberger; M Kelly
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Progress report intestinal protozoa.

Authors:  R Knight; S G Wright
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

3.  Another approach to in vivo estimation of genetic damage in humans.

Authors:  R W Pero; F Mitelman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

4.  Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole.

Authors:  Annamaria Buschini; Lisa Ferrarini; Susanna Franzoni; Serena Galati; Mirca Lazzaretti; Francesca Mussi; Cristina Northfleet de Albuquerque; Tânia Maria Araújo Domingues Zucchi; Paola Poli
Journal:  J Parasitol Res       Date:  2009-10-21

5.  Detection of Trichomonas vaginalis in pregnant women with the InPouch TV culture system.

Authors:  D Draper; R Parker; E Patterson; W Jones; M Beutz; J French; K Borchardt; J McGregor
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

6.  Predictors of Failure from Primary Therapy for Giardiasis in San Diego: A Single Institution Retrospective Review.

Authors:  Anjan Debnath; Sharon L Reed; Sheldon R Morris
Journal:  Pathogens       Date:  2019-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.